Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Nagarjun Rangaraj"'
Autor:
Nagarjun Rangaraj, Sunitha Sampathi, Vijayabhaskarreddy Junnuthula, Praveen Kolimi, Preethi Mandati, Sagar Narala, Dinesh Nyavanandi, Sathish Dyawanapelly
Publikováno v:
Pharmaceutics, Vol 14, Iss 9, p 1807 (2022)
Among various drug administration routes, oral drug delivery is preferred and is considered patient-friendly; hence, most of the marketed drugs are available as conventional tablets or capsules. In such cases, the administration of drugs with or with
Externí odkaz:
https://doaj.org/article/f131d57ba1774d20ab5b1635337b51b7
Autor:
Aditi Bhat, Harshita Dalvi, Harsha Jain, Nagarjun Rangaraj, Shashi Bala Singh, Saurabh Srivastava
Publikováno v:
Current Research in Pharmacology and Drug Discovery, Vol 2, Iss , Pp 100012- (2021)
Neurodegenerative disorders which affects a larger population pose a great clinical challenge. These disorders impact the quality of life of an individual by damaging the neurons, which are the unit cells of the brain. Clinicians are faced with the g
Externí odkaz:
https://doaj.org/article/2776e2948e9b47c283b896b4536f2df5
Autor:
Rajeev Singh Raghuvanshi, Saurabh Srivastava, Saurabh Shah, Nagarjun Rangaraj, Shweta Nene, Shashi Bala Singh
Publikováno v:
Drug Development and Industrial Pharmacy. 46:1735-1746
Nano-medicine is the fastest growing field in pharmaceutical industry today. However, there still exist several hurdles preceding its clinical translation. This review provides insights on the guidelines for nanomaterials provided by the US-FDA (Unit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::421c7f67b27c47139c4b94fddd73e381
https://doi.org/10.1080/03639045.2020.1821055
https://doi.org/10.1080/03639045.2020.1821055
Autor:
Charles Oluwaseun Adetunji, Dickson Adom, Muhammad Akram, Annu Amanjot, Idongesit Archibong, Imran Aslan, Chinaza Godswill Awuchi, Aditi Bhat, Subhash Chandra, Isaac Cherian, Jude C. Chikwendu, Genevieve Dable-Tupas, Harshita Dalvi, Giovanna Del Gaudio, Valentina Della Corte, Cecile Melisse P. Derecho, Chukwuebuka Egbuna, Folorunso Oludayo Fasina, Peculiar Feenna Onyekere, Ajay Kumar Gautam, Dinesh B. Hanchate, Jonathan C. Ifemeje, Harsha Jain, Johra Khan, Sudhakar Kondal Krishnamurthy, Goutam Kumar Jena, Fanuel Lampiao, Aravind Madhu, Sheikh Mansoor, Arifullah Mohammed, Andrew G. Mtewa, Suchetana Mukherjee, Lalit Mohan Nainwal, Giuliana Nevola, Kennedy J. Ngwira, Alloysius Chibuike Ogodo, Patrick Ogwang, Hedmon Okella, Ahmed Olatunde, Michael C. Olisah, Olutosin Ademola Otekunrin, Oluwaseun Aramide Otekunrin, Abhishek Pandey, Ch Niranjan Patra, Kingsley C. Patrick-Iwuanyanwu, Amuthalakshmi Periasamy, Rajeev Singh Raghuvanshi, Nagarjun Rangaraj, Yousef Rasmi, Punna Rao Ravi, Muhammad Riaz, Ibrahim Alhaji Sabo, Sarla Saklani, Parthasarathy Saravanan, Barbara Sawicka, Bogusław Sawicki, Saurabh Shah, Chandan Shivamallu, Shashi Bala Singh, Dwaipayan Sinha, Saurabh Srivastava, J. Sruti, null Suman, Habibu Tijjani, Mohamed Mohamed Tolba Said, Casim U. Tolo, Chukwuemelie Z. Uche, Ihtisham Ulhaq, Krishnan Umachandran, Uchechukwu Victor Nwankwo, Anke Weisheit, Tadele Mekuriya Yadesa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f21754ab5a272ba1e49da5f21f74092c
https://doi.org/10.1016/b978-0-323-85156-5.01002-6
https://doi.org/10.1016/b978-0-323-85156-5.01002-6
Autor:
Harsha Jain, Geetanjali Devabattula, Aditi Bhat, Harshita Dalvi, Nagarjun Rangaraj, Chandraiah Godugu, Saurabh Srivastava
This work investigates the synergistic potential of the nanostructured lipid carrier (NLC) gel of Ibrutinib with Curcumin as a repurposing strategy to treat psoriasis. In the present work, various components such as liquid lipid, solid lipid, and sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ed3a6513be49be2d8d525213406d77b
Autor:
Saurabh Srivastava, Aditi Bhat, Shashi Bala Singh, Nagarjun Rangaraj, Harsha Jain, Harshita Dalvi
Publikováno v:
Current Research in Pharmacology and Drug Discovery, Vol 2, Iss, Pp 100012-(2021)
Current Research in Pharmacology and Drug Discovery
Current Research in Pharmacology and Drug Discovery
Neurodegenerative disorders which affects a larger population pose a great clinical challenge. These disorders impact the quality of life of an individual by damaging the neurons, which are the unit cells of the brain. Clinicians are faced with the g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6e9d4af8c611824007fd723231b2a7d
http://www.sciencedirect.com/science/article/pii/S2590257120300146
http://www.sciencedirect.com/science/article/pii/S2590257120300146
Publikováno v:
Drug delivery and translational research. 10(5)
Ibrutinib (IBR) is the choice of drug for the treatment of chronic lymphocytic leukaemia (CLL) and mantle cell lymphoma (MCL). IBR has low oral bioavailability of 2.9% owing to its high first pass metabolism. Present study was aimed to develop the na
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d1a1a30190f10a44dc193b3b574e26c
https://pubmed.ncbi.nlm.nih.gov/32519202
https://pubmed.ncbi.nlm.nih.gov/32519202
Publikováno v:
International journal of pharmaceutics. 581
Nanogels, also known as next generation drug delivery systems are in the limelight of the research owing to their advantages like high loading, tunability of size, stimuli responsiveness, sustained drug release via in situ gelling mechanisms, stabili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0af9d3b242424b5c7828947e2303078
https://pubmed.ncbi.nlm.nih.gov/32240803
https://pubmed.ncbi.nlm.nih.gov/32240803
Publikováno v:
AAPS PharmSciTech. 20
Present study was aimed to increase the oral bioavailability and reduce the fast fed variability of Ibrutinib by developing nanosuspension by simple precipitation-ultrasonication method. A three factor, three level, box-behnken design was used for fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2d9442c209e574a6836be142d246c54
https://doi.org/10.1208/s12249-019-1524-7
https://doi.org/10.1208/s12249-019-1524-7